Gene · 93
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative analyses of biomarkers and pathways for heart failure. | BMC Med Genomics | 2022 | 35346191 | PubTator, text mining | PubMed |
| The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspective. | Nat Commun | 2022 | 35338126 | PubTator, text mining | PubMed |
| Cancer-Related Cachexia: The Vicious Circle between Inflammatory Cytokines, Skeletal Muscle, Lipid Metabolism and the Possible Role of Physical Training. | Int J Mol Sci | 2022 | 35328423 | PubTator, text mining | PubMed |
| At the Intersection of Cardiology and Oncology: TGFβ as a Clinically Translatable Therapy for TNBC Treatment and as a Major Regulator of Post-Chemotherapy Cardiomyopathy. | Cancers (Basel) | 2022 | 35326728 | PubTator, text mining | PubMed |
| Cardiac Cachexia: Unaddressed Aspect in Cancer Patients. | Cells | 2022 | 35326441 | PubTator, text mining | PubMed |
| Lack of Tgfbr1 and Acvr1b synergistically stimulates myofibre hypertrophy and accelerates muscle regeneration. | Elife | 2022 | 35323108 | PubTator, text mining | PubMed |
| Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis. | Dis Markers | 2022 | 35320950 | PubTator, text mining | PubMed |
| Chemotherapy-induced cachexia and model-informed dosing to preserve lean mass in cancer treatment. | PLoS Comput Biol | 2022 | 35312676 | PubTator, text mining | PubMed |
| A network of transcription factors governs the dynamics of NODAL/Activin transcriptional responses. | J Cell Sci | 2022 | 35302162 | PubTator, text mining | PubMed |
| Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within. | Front Pharmacol | 2022 | 35295334 | PubTator, text mining | PubMed |
| Network pharmacology and molecular docking analysis reveals the mechanism of asiaticoside on COVID-19. | Ann Transl Med | 2022 | 35280425 | PubTator, text mining | PubMed |
| Bone morphogenetic protein receptor 1α promotes osteolytic lesion of oral squamous cell carcinoma by SHH-dependent osteoclastogenesis. | Cancer Sci | 2022 | 35279920 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Exercise Therapy for People With Sarcopenic Obesity: Myokines and Adipokines as Effective Actors. | Front Endocrinol (Lausanne) | 2022 | 35250869 | PubTator, text mining | PubMed |
| Epigenetic regulation of inflammation by microRNAs in post-infectious bronchiolitis obliterans. | Clin Transl Immunology | 2022 | 35228871 | PubTator, text mining | PubMed |
| Regulatory spine RS3 residue of protein kinases: a lipophilic bystander or a decisive element in the small-molecule kinase inhibitor binding? | Biochem Soc Trans | 2022 | 35226061 | PubTator, text mining | PubMed |
| The Potential to Fight Obesity with Adipogenesis Modulating Compounds. | Int J Mol Sci | 2022 | 35216415 | PubTator, text mining | PubMed |
| Construction and Validation of an Immune-Related lncRNA Prognosis Model for Thyroid Cancer. | Comb Chem High Throughput Screen | 2022 | 35209814 | PubTator, text mining | PubMed |
| The Bright and the Dark Side of TGF-β Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications. | Cancers (Basel) | 2022 | 35205692 | PubTator, text mining | PubMed |
| Growth differentiation factor-11 downregulates steroidogenic acute regulatory protein expression through ALK5-mediated SMAD3 signaling pathway in human granulosa-lutein cells. | Reprod Biol Endocrinol | 2022 | 35183204 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/93/papers?page=19